Quest Diagnostics (DGX) Operating Leases (2019 - 2025)
Historic Operating Leases for Quest Diagnostics (DGX) over the last 7 years, with Q3 2025 value amounting to $534.0 million.
- Quest Diagnostics' Operating Leases fell 165.75% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 165.75%. This contributed to the annual value of $535.0 million for FY2024, which is 1930.62% down from last year.
- Quest Diagnostics' Operating Leases amounted to $534.0 million in Q3 2025, which was down 165.75% from $540.0 million recorded in Q2 2025.
- Over the past 5 years, Quest Diagnostics' Operating Leases peaked at $679.0 million during Q4 2021, and registered a low of $489.0 million during Q1 2024.
- Over the past 5 years, Quest Diagnostics' median Operating Leases value was $508.0 million (recorded in 2023), while the average stood at $536.6 million.
- In the last 5 years, Quest Diagnostics' Operating Leases skyrocketed by 2298.29% in 2021 and then plummeted by 1930.62% in 2024.
- Over the past 5 years, Quest Diagnostics' Operating Leases (Quarter) stood at $679.0 million in 2021, then dropped by 4.12% to $651.0 million in 2022, then rose by 1.84% to $663.0 million in 2023, then decreased by 19.31% to $535.0 million in 2024, then decreased by 0.19% to $534.0 million in 2025.
- Its Operating Leases stands at $534.0 million for Q3 2025, versus $540.0 million for Q2 2025 and $538.0 million for Q1 2025.